Significant association between ABO blood group and pancreatic cancer

doi:10.3748/wjg.v16.i44.5588

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3848)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

349

HTML

3355

Tables (1-1)

144

Sum=3848

Nov 28, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 28, 2010; 16(44): 5588-5591
Published online Nov 28, 2010. doi: 10.3748/wjg.v16.i44.5588

Significant association between ABO blood group and pancreatic cancer

Julia B Greer, Mark H Yazer, Jay S Raval, M Michael Barmada, Randall E Brand, David C Whitcomb

Julia B Greer, Randall E Brand, David C Whitcomb, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, 3708 5th Ave, Pittsburgh, PA 15213, United States

Mark H Yazer, Jay S Raval, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States

Mark H Yazer, The Institute for Transfusion Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, United States

M Michael Barmada, David C Whitcomb, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, United States

David C Whitcomb, University of Pittsburgh Cancer Institute, 5150 Centre Avenue, Pittsburgh, PA 15232, United States

Author contributions: Greer JB was responsible for study concept and design, acquisition of data, drafting and critical revision of the manuscript for important intellectual content; Yazer MH and Whitcomb DC were responsible for study concept and design, acquisition of data, study supervision, and drafting and critical revision of the manuscript for important intellectual content; Raval JS and Brand RE were responsible for acquisition of data, interpretation of data, and drafting the article; Barmada MM was responsible for analysis and interpretation of data and drafting the article.

Supported by The Frieda G. and Saul F. Shapira BRCA Cancer Research Program (Greer JB, Whitcomb DC), the Wayne Fusaro Pancreatic Cancer Research Fund (Whitcomb DC) and the Jack F. Walsh Pancreatic Cancer Foundation (Brand RE)

Correspondence to: Mark H Yazer, MD, FRCPC, The Institute for Transfusion Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, United States. myazer@itxm.org

Telephone: +1-412-2097522 Fax: +1-412-2097325

Received: January 23, 2010
Revised: April 12, 2010
Accepted: April 19, 2010
Published online: November 28, 2010

Core Tip